In 2013, Norway established a framework, "New Methods," for the introduction of innovations into the healthcare system through either a national or hospital-based health technology assessment. In this framework, all innovations should undergo HTA before being funded.
In October 2022, Ordering Forum for New Methods invited interested parties regarding hand-held electrocardiogram (ECG) devices connected to an app for diagnosing atrial fibrillation in adults (e.g., KardiaMobile). Information (a completed input form) shall be submitted to nyemethoder@helse-sorost.no before November 29, 2022.
Ordering Forum will be held on December 12, 2022, to decide whether the method will undergo evaluation at the national level.
See more information in Norwegian here and here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).